National Health Investors (NYSE:NHI) Stock Rating Lowered by StockNews.com

National Health Investors (NYSE:NHIGet Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Thursday.

Other equities analysts also recently issued reports about the company. Truist Financial raised their price target on National Health Investors from $55.00 to $58.00 and gave the stock a “hold” rating in a research note on Thursday, April 4th. Wedbush upped their price target on shares of National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of National Health Investors in a research note on Tuesday, January 30th. They issued a “buy” rating and a $69.00 price objective on the stock. BMO Capital Markets upgraded shares of National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price for the company in a research report on Tuesday, March 12th. Finally, Wells Fargo & Company upgraded shares of National Health Investors from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $55.00 to $63.00 in a research report on Monday, February 26th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $60.50.

Check Out Our Latest Stock Analysis on NHI

National Health Investors Stock Up 1.8 %

Shares of National Health Investors stock opened at $61.52 on Thursday. National Health Investors has a twelve month low of $47.54 and a twelve month high of $62.93. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90. The company’s 50 day moving average is $58.80 and its 200 day moving average is $55.30. The company has a market cap of $2.67 billion, a price-to-earnings ratio of 19.65 and a beta of 0.95.

Insider Buying and Selling at National Health Investors

In related news, Director Charlotte A. Swafford bought 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The shares were purchased at an average price of $58.69 per share, with a total value of $586,900.00. Following the completion of the acquisition, the director now owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 7.26% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

Large investors have recently made changes to their positions in the company. Janney Montgomery Scott LLC grew its holdings in National Health Investors by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 23,707 shares of the real estate investment trust’s stock valued at $1,324,000 after buying an additional 200 shares in the last quarter. Van ECK Associates Corp grew its holdings in shares of National Health Investors by 4.3% in the third quarter. Van ECK Associates Corp now owns 4,889 shares of the real estate investment trust’s stock valued at $251,000 after purchasing an additional 202 shares in the last quarter. Sound Income Strategies LLC increased its position in National Health Investors by 33.5% in the fourth quarter. Sound Income Strategies LLC now owns 916 shares of the real estate investment trust’s stock worth $51,000 after purchasing an additional 230 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in National Health Investors by 6.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,979 shares of the real estate investment trust’s stock valued at $222,000 after purchasing an additional 238 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in National Health Investors by 3.2% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 7,865 shares of the real estate investment trust’s stock valued at $406,000 after purchasing an additional 243 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

About National Health Investors

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Read More

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.